Bicycle Therapeutics plc (BCYC)
Nasdaq: BCYC · Pharmaceutical Preparations · Cambridge, GB · filing with the SEC since 2018
Who owns Bicycle Therapeutics plc
As filed with the SECHolders of 5% or more
3
Forbion Growth Opportunities Fund II Cooperatief U.A. holds 7.3% of Ordinary shares, nominal value 0.01 per share, as its SCHEDULE 13G filed Dec 19, 2024 says.
Directors and officers
21
report now, of 37 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Forbion Growth Opportunities Fund II Cooperatief U.A.
SCHEDULE 13G · filed Dec 19, 2024 · Ordinary shares, nominal value 0.01 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share · 6.75% in May 15, 2026
Long Focus Capital Management, LLC
SCHEDULE 13G · filed May 15, 2026 · American Depositary Shares, each representing 1 ordinary share
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed Aug 14, 2025 · Ordinary Shares, nominal value 0.01 GBP per share · reported falling below 5%, from 7.8% in May 15, 2025
Raymond Debbane
SCHEDULE 13G/A · filed May 4, 2026 · Ordinary Shares, nominal value GBP 0.01 per share · reported falling below 5%, from 6.3% in Mar 3, 2026
Deep Track Capital, LP
SCHEDULE 13G/A · filed Aug 14, 2025 · American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share · reported falling below 5%, from 5.67% in May 15, 2025
Westfield Capital Management Company, L.P.
SCHEDULE 13G/A · filed Mar 4, 2026 · Common Stock · reported falling below 5%, from 0% in Mar 3, 2026
What BCYC reports owning in othersstakes of 5% or more, and other ties
Bicycle Therapeutics plc reports no stake in another company in the record.
Insider tradesForm 4
49sales
0purchases
14sales on a scheduled plan
8people selling
$500,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 7, 2025 to Oct 7, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 7, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 50 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Lee Kevin | CHIEF EXECUTIVE OFFICER | 8 | $200,000 | 0 | 0 | $0 |
| Young Alethia | Chief Financial Officer | 3 | $100,000 | 3 | 0 | $0 |
| Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | 8 | $100,000 | 0 | 0 | $0 |
| Skynner Michael | CHIEF SCIENTIFIC OFFICER | 8 | $100,000 | 0 | 0 | $0 |
| Thompson Travis Alvin | Chief Financial Officer | 8 | $0 | 0 | 0 | $0 |
| Perry Jennifer Scott | Chief Operating Officer | 11 | $0 | 11 | 0 | $0 |
| Milnes Alistair | CHIEF OPERATING OFFICER | 2 | $0 | 0 | 0 | $0 |
| Swanton Robert Charles | director | 1 | $0 | 0 | 0 | $0 |